Panel Discussion: Defining Peri-Procedural MI in Clinical Trials

Tuesday, February 28, 2023

11:41 AM – 12:05 PM ET

Panel Moderator(s)

Donald E. Cutlip, MD, FACC (he/him/his)

Vice Chair, Department of Medicine
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States

Disclosure information not submitted.
P F Adrian Magee, MD

Physician/Medical Officer (Cardiology)
FDA
Silver Spring, Maryland, United States

No relationships to disclose

Panel Discussant(s)

Paula V. Caposino, PhD (she/her/hers)

Branch Chief, Cardio-Renal Diagnostics
FDA
Silver Spring, Maryland, United States

Disclosure(s): No financial relationships to disclose
Rafael Cavalcante, MD (he/him/his)

Vice President, Medical Affairs
Boston Scientific
Newton, Massachusetts, United States

Disclosure(s): Boston Scientific: Employee (Ongoing)
Hector M. Garcia-Garcia, MD, PhD

Director of Invasive Imaging Core Laboratory
MedStar Washington Hospital Center
Washington, District of Columbia, United States

Disclosure(s): No relevant disclosure to display
Lydia Glaw, PhD

Assistant Director
US FDA

Disclosure(s): AstraZeneca Pharmaceuticals: Employee (Ongoing), Salary (Ongoing)
P F Adrian Magee, MD

Physician/Medical Officer (Cardiology)
FDA
Silver Spring, Maryland, United States

No relationships to disclose
EM

Eugene P. McFadden, MD (he/him/his)

Cardiologist
Cork University Hospital
Cork, Cork, Ireland

No relationships to disclose
Gregg W. Stone, MD, FACC, MSCAI (he/him/his)

Physician
Mount Sinai
New York, New York, United States

Disclosure(s): Abbott, Abiomed, Bioventrix, Cardiovascular Systems Inc, Phillips, Biosense-Webster, Shockwave, Vascular Dynamics, Pulnovo and V-wave: University Grants/Research Support (Ongoing); Abiomed, CorFlow, Apollo Therapeutics, Cardiomech, Gore, Amgen, Millennia Biopharma: Consultant (Terminated); Ancora, Cagent, Applied Therapeutics, Biostar family of funds, SpectraWave, Orchestra Biomed, Aria, Cardiac Success, Valfix, Xenter: Stockholder/Ownership Interest (excluding diversified mutual funds) (Ongoing); Medtronic, Pulnovo, Infraredx: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated); Valfix, TherOx, Robocath, HeartFlow, Ablative Solutions, Miracor, Neovasc, Ancora, Vectorious, Elucid Bio, Occlutech, Impulse Dynamics, Adona Medical: Consultant (Ongoing)
JW

Jacqueline Wieneke, MD

Disclosure information not submitted.

Disclosure(s):

Paula V. Caposino, PhD: No financial relationships to disclose

Rafael Cavalcante, MD: Boston Scientific: Employee (Ongoing)

Hector M. Garcia-Garcia, MD, PhD: No relevant disclosure to display

Lydia Glaw, PhD: AstraZeneca Pharmaceuticals: Employee (Ongoing), Salary (Ongoing)

Roxana Mehran, MD, FACC, FACP, FCCP, FESC, FAHA, MSCAI: Abbot, abiomed, alleviant medical, amgen, am-pharma, arena, AstraZeneca, Atricure: Grant/Research Support (Ongoing); Applied Therapeutics, Elixir Medical, Stel, ControlRad (spouse): Stock-privately held company (Ongoing); Bayer, Biosensors, Biotronik, Boston Scientific, Bristol-Myers Squibb, CardiaWave, CeloNova, Chiesi: Grant/Research Support (Ongoing); Cine-Med Research, Ionis Pharmaceuticals, Novartis, Novo Nordisk, Vectura, WebMD: Consultant (Ongoing); Concept Medical, CSL Behring, Cytosorbents, Daiichi Sankyo, Element Science, Faraday, Filterlex Medical, Humacyte, Idorsia Pharmaceuticals, Janssen, Mediasphere, Medtelligence: Grant/Research Support (Ongoing); Medtronic, Novartis, OrbusNeich, Penumbra, PhaseBio, Philips, Pi-Cardia, PLx Pharma, Protembis, RenalPro, RM Global, Shockwave, Vivasure, Zoll: Grant/Research Support (Ongoing); Scientific Advisory Board for AMA, ACC (BOT Member, SC Member CTR Program), SCAI (Women in Innovations Committee Member), JAMA Cardiology Associate Editor; Faculty CRF: Scientific Advisory Board (Ongoing)

Gregg W. Stone, MD, FACC, MSCAI: Abbott, Abiomed, Bioventrix, Cardiovascular Systems Inc, Phillips, Biosense-Webster, Shockwave, Vascular Dynamics, Pulnovo and V-wave: University Grants/Research Support (Ongoing); Abiomed, CorFlow, Apollo Therapeutics, Cardiomech, Gore, Amgen, Millennia Biopharma: Consultant (Terminated); Ancora, Cagent, Applied Therapeutics, Biostar family of funds, SpectraWave, Orchestra Biomed, Aria, Cardiac Success, Valfix, Xenter: Stockholder/Ownership Interest (excluding diversified mutual funds) (Ongoing); Medtronic, Pulnovo, Infraredx: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated); Valfix, TherOx, Robocath, HeartFlow, Ablative Solutions, Miracor, Neovasc, Ancora, Vectorious, Elucid Bio, Occlutech, Impulse Dynamics, Adona Medical: Consultant (Ongoing)